Rare diseases
Investigational molecules
Locations
Neuhofstrasse 21, 6340
Novocure GmbH supports clinical research in metastatic pancreatic ductal adenocarcinoma, with a focus on treatment settings for patients receiving first-line systemic therapy. The studies centre on tumor treating fields in combination with established chemotherapy and immunotherapy approaches.
The therapeutic interest in this area reflects work at the intersection of solid tumor management, systemic anticancer therapy, and device-based oncology.
Novocure GmbH runs clinical trials in conditions such as Glioblastoma, Pancreatic carcinoma metastatic, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaCzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
